Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6424 -0.0494 (-7.14%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6400 -0.0024 (-0.37%) 19:50 ET
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.6390
Day High
0.6900
Open 0.6900
Previous Close 0.6918 0.6918
Volume 1,601,000 1,601,000
Avg Vol 6,128,605 6,128,605
Stochastic %K 71.37% 71.37%
Weighted Alpha -81.73 -81.73
5-Day Change +0.0058 (+0.91%) +0.0058 (+0.91%)
52-Week Range 0.3941 - 5.2500 0.3941 - 5.2500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,263
  • Shares Outstanding, K 87,583
  • Annual Sales, $ 0 K
  • Annual Income, $ -111,130 K
  • EBIT $ -116 M
  • EBITDA $ -108 M
  • 60-Month Beta 2.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.59
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.32
  • Most Recent Earnings $-0.28 on 03/10/25
  • Next Earnings Date 05/13/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 257.43% ( -48.47%)
  • Historical Volatility 247.59%
  • IV Percentile 81%
  • IV Rank 39.76%
  • IV High 626.84% on 02/28/25
  • IV Low 13.65% on 07/12/24
  • Put/Call Vol Ratio 0.04
  • Today's Volume 146
  • Volume Avg (30-Day) 394
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 12,063
  • Open Int (30-Day) 12,100

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.18
  • Number of Estimates 6
  • High Estimate -0.14
  • Low Estimate -0.31
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +55.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3941 +63.00%
on 03/04/25
Period Open: 1.0100
1.0250 -37.33%
on 03/03/25
-0.3676 (-36.40%)
since 02/28/25
3-Month
0.3941 +63.00%
on 03/04/25
Period Open: 1.5000
1.6300 -60.59%
on 01/07/25
-0.8576 (-57.17%)
since 12/27/24
52-Week
0.3941 +63.00%
on 03/04/25
Period Open: 5.2300
5.2500 -87.76%
on 04/01/24
-4.5876 (-87.72%)
since 03/28/24

Most Recent Stories

More News
Top 3 Insider Stock Buys in March—Are They Still Good in April?

Insider buying of stocks like Matador Resources, Tenaya Therapeutics, and FirstSun picked up in March and points to value for investors.

MTDR : 50.51 (-1.92%)
TNYA : 0.6424 (-7.14%)
FSUN : 37.75 (-1.95%)
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models

TNYA : 0.6424 (-7.14%)
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session

TNYA : 0.6424 (-7.14%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.6424 (-7.14%)
CSCI : 3.04 (-1.14%)
MLYS : 14.66 (-2.27%)
SWTX : 47.41 (-0.17%)
MGX : 1.4800 (-3.90%)
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

TNYA : 0.6424 (-7.14%)
Tenaya Therapeutics Announces Pricing of Public Offering

TNYA : 0.6424 (-7.14%)
Tenaya Therapeutics Announces Proposed Public Offering

TNYA : 0.6424 (-7.14%)
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences

TNYA : 0.6424 (-7.14%)
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

TNYA : 0.6424 (-7.14%)
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones

TNYA : 0.6424 (-7.14%)

Business Summary

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH...

See More

Key Turning Points

3rd Resistance Point 0.7263
2nd Resistance Point 0.7081
1st Resistance Point 0.6753
Last Price 0.6424
1st Support Level 0.6243
2nd Support Level 0.6061
3rd Support Level 0.5733

See More

52-Week High 5.2500
Fibonacci 61.8% 3.3950
Fibonacci 50% 2.8221
Fibonacci 38.2% 2.2491
Last Price 0.6424
52-Week Low 0.3941

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies